|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 31/439 | (2006.01) |
| A61K 31/4995 | (2006.01) | ||
| A61K 31/55 | (2006.01) | ||
| A61K 31/553 | (2006.01) | ||
| A61P 31/04 | (2006.01) |
| (11) | Number of the document | 2279737 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10177533.6 |
| Date of filing the European patent application | 2003-01-27 | |
| (97) | Date of publication of the European application | 2011-02-02 |
| (45) | Date of publication and mention of the grant of the patent | 2012-10-31 |
| (46) | Date of publication of the claims translation | 2013-02-25 |
| (30) | Number | Date | Country code |
| 0200951 | 2002-01-28 | FR |
| (72) |
Aszodi, Jozsef, FR
Fromentin, Claude, FR
Lampilas, Maxime, FR
Rowlands, David, Alun, GB
|
| (73) |
Pfizer Ireland Pharmaceuticals,
Operations Support Group Ringaskiddy, Co.Cork,
IE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Heterocikliniai junginiai, veiksmingi kaip beta laktamazės slopikliai |
| Heterocyclic compounds that are active as beta lactamase inhibitors |
| Payment date | Validity (years) | Amount | |
| 2022-01-10 | 347.00 EUR |